Honoring a legend: A beautiful tribute to Dr. Christopher Fletcher—visionary leader, world-renowned soft tissue pathologist, and mentor to many. Portrait by Dr. Christopher French. Thank you, Dr. French, for capturing the spirit of a true icon in pathology. 💫 #PathTwitter

Playing for the 🏆 this weekend #ChantsUp I ConwayDowntownAlive

Another great year for Team GU! I am so proud of our graduating GU pathology fellows - Katie Saunders, DO and Jessica Williams - who are moving on to do great things in Maine and Utah, respectively. Well done this year! 🔬#gupath #gupathrocks Brigham and Women's Pathology

Mass General Brigham (MGB) Pathology is now accepting applications for our 2027-2028 combined BWH/MGH GU Pathology Fellowship. If you love GU pathology 🔬 and Boston 🦞, consider applying @ [email protected] #gupath #gupathrocks Mass General Brigham Pathology

I am so honored & humbled to have received the Pier Paci Teaching Award from the BWH/MGB residents & fellows this year. Teaching & mentoring is the best part of my job, and together we work to provide the best patient care. Thank you for recognizing my efforts! 🔬🫶Brigham and Women's Pathology

Most Americans (77%) oppose cutting federal funding for medical research because it SAVES lives. Lives like mine. Trump’s proposed cuts risk progress in all diseases, including kidney cancer. Stop the craziness. Ed Markey Elizabeth Warren Congresswoman Ayanna Pressley Rep. Stephen F. Lynch KidneyCAN

The results are in! We’re thrilled to share the 2025 I Know a Fighter Photo contest winner! 📸 Thank you to everyone who submitted photos. Every submission this year captured what it means to live boldly with NF. 💙💚 View the winner & finalists here: go.ctf.org/photocontest20….

Here is an update on medullary RCC. Thank you Pavlos Msaouel for your tremendous contribution to this article and thanks to Michelle_Hirsch (Donovan) for the invitation Open access at: journals.sagepub.com/doi/full/10.32…

Excited to share our review on renal tumors with defined molecular alterations! journals.sagepub.com/doi/full/10.32…

Chromophobe renal cell carcinoma is difficult to treat - Research in Journal of Clinical Oncology provides better understanding of this rare kidney cancer, potential treatment pathways & immunotherapy strategies. Dana-Farber Lank Center for Genitourinary Oncology Eddy Saad Chris Labaki BIDMC ➡️ bit.ly/3IhLT8d

Pathologist representation at this year’s #KCRS25, one of my most important and favorite meetings each year. 🔬🩺🩻 #gupathology #workingtogethertofightRCC Payal Kapur Ying-Bei Chen, MD, PhD ROHIT MEHRA KidneyCAN OncoAlert UroToday.com

We’re proud to present the KidneyCAN Catalyst Award to Dr. Rana McKay of UC San Diego. Dr. McKay is a leader whose work has helped move the field of kidney cancer forward through groundbreaking research, clinical collaboration, and a deep commitment to patients and advocacy. Her

🔔KEYNOTE-B61 longest follow up (3 years!) for papillary, chromophobe , translocation and unclassified RCC. Congrats to Laurence Albiges Martin Voss ORR 51% , mPFS 18mo, mOS 42.5 Merck #KCRS25

What we did in Boston this week at #KCRS2025 will change lives worldwide. Scientists, doctors,patients, industry, and advocates—all in one room—accelerating cures + driving hope. Thank you @KidneyCAN for this powerful, patient-focused gathering. #KidneyCancer #ResearchToCures

And that is wrap for #KCRS2025 Hans Hammers Bryan Lewis KidneyCAN

Thx Dan! Yes! So important to distinguish for appropriate patient care! ‘Shoulder’ of PUC is NCCN intermediate risk vs high risk for UCIS. It matters! 🔬

Daniel Berney Michelle_Hirsch (Donovan) couldn’t agree more! study we did on this topic 👇🏽 doi.org/10.1093/ajcp/a…

Daniel Berney Michelle_Hirsch (Donovan) Diagnosis of CIS in fragmented TURBT specimens is often difficult and subjective. Only CIS away from papillary tumour should warrant categorisation as very high risk (potential upfront cystectomy). Have a high threshold for diagnosing CIS in TURBT specimens.